Apg Asset Management N.V. Hutchmed (China) LTD Transaction History

Apg Asset Management N.V.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$15.52 - $35.65 $122,499 - $281,385	-7,893 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$35.66 - $42.94 $120,281 - $144,836	-3,373 Reduced 29.94%	7,893 $249,000
Q2 2021 Aug 13, 2021	SELL	$23.7 - $39.27 $134,355 - $222,621	-5,669 Reduced 33.48%	11,266 $373,000
Q1 2021 May 14, 2021	SELL	$27.01 - $36.8 $147,609 - $201,111	-5,465 Reduced 24.4%	16,935 $407,000
Q3 2020 Nov 12, 2020	BUY	$25.8 - $34.61 $136,740 - $183,433	5,300 Added 30.99%	22,400 $617,000
Q2 2020 Aug 14, 2020	BUY	$17.65 - $28.05 $105,899 - $168,300	6,000 Added 54.05%	17,100 $420,000
Q1 2020 May 15, 2020	BUY	$15.19 - $29.51 $168,609 - $327,561	11,100 New	11,100 $198,000

6.88M

6.2K

1.1K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.19B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

Stay updated on Apg Asset Management N.V. with notifications on news.